Guelph, Ontario--(Newsfile Corp. - December 29, 2020) - ZEN Graphene Solutions Ltd. ("ZEN" or the "Company") (TSXV: ZEN) (OTC: ZENYF) is pleased to announce the following: Preliminary cytotoxicity ...

STEMart, a provider of integrated medical device CRO services dedicated to medical device and diagnostic clinical development, recently introduces a series of medical device cytotoxicity testing ...

Progress is being made when it comes to moving away from guinea pigs and rabbits, and developing lab-based tests acceptable to FDA. Thor Rollins, Nelson Laboratories While there are many obstacles on ...

Biocompatibility testing is a necessary part of any medical device validation process. It is governed by FDA’s ISO 10993 guidance document, a seemingly rigid statement that provides a general matrix ...